Cystic fibrosis cystic fibrosis in the Japanese Population

Japanese Journal of Chest Diseases

Volumn 68, Issue 8, 2009, Pages 693-705

  Yoshimura, Kunihiko ^a   Anzai, Chieko ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Bronchiectasis; Cftr gene; Chloride channel; Cystic fibrosis; Respiratory tract infection with pseudomonas aeruginoza

Indexed keywords

EID: 69749121446     PISSN: 03853667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Welsh MJ, Ramsey BW, Accurso F, et al. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, et al, editors. The metabolic and molecular basis of inherited disease, 8th ed. New York: McGraw-Hill 2000:5121-88.
2. Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science 1992;256:774-9.
3. Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathological study. Am J Dis Child 1938;56:344-99.
4. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-4.
5. Tsui L-C. The cystic fibrosis transmembrane conductance regulator gene. Am J Respir Crit Care Med 1995; 151: S47-S53.
6. Cystic Fibrosis Genetic Analysis Consortium. Cystic fibrosis mutation data base. 2009. Available from http://www.genet.sickkids.on.ca/cftr/. (cited Apr. 2009)
7. Frizzell RA. Function of the cystic fibrosis transmembrane conductance regulator protein. Am J Respir Crit Care Med 1995; 151: S54-S8.
8. Winter MC, Welsh MJ. Stimulation of CFTR activity by its phosphorylated R domain. Nature 1997;389:294-6.
9. Egan M, Flotte T, Afione S, et al. Defective regulation of outwardly rectifying Cl-channels by protein kinase A corrected by insertion of CFTR. Nature 1992;358:581-4.
10. Pier GB, Grout M, Zaidi TS, et al. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 1996;271:64-7.
11. Pier GB, Grout M, Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci USA 1997;94:12088-93.
12. Dorfman R, Sandford A, Taylor C, et al. Complex two-gene modulation of lung disease severity in children with cystic fibrosis. J Clin Invest 2008;118:1040-9.
13. Farrell PM, Rosenstein BJ, White TB, et al; Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008; 153: S4-S14.
14. LeGrys VA, Yankaskas JR, Quittell LM, et al; Cystic Fibrosis Foundation. Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. J Pediatr 2007;151:85-9.
15. Elizur A, Cannon CL, Ferkol TW. Airway inflammation in cystic fibrosis. Chest. 2008;133:489-95.
16. Homma H, Yamanaka A, Tanimoto S, et al. Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 1983;83:63-9.
17. Davis SD, Fordham LA, Brody AS, et al. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 2007;175:943-50.
18. Robinson TE. Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease. Proc Am Thorac Soc 2007;4:310-5.
19. Tiddens HA. Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr Respir Rev 2006;7:202-8.
20. Ramsey B, Richardson MA. Impact of sinusitis in cystic fibrosis. J Allergy Clin Immunol 1992;90:547-52.
21. Davidson TM, Murphy C, Mitchell M, et al. Management of chronic sinusitis in cystic fibrosis. Laryngoscope 1995;105:354-8.
22. Brihaye P, Clement PA, Dab I, et al. Pathological changes of the lateral nasal wall in patients with cystic fibrosis (mucoviscidosis). Int J Pediatr Otorhionolaryngol 1994;28:141-7.
23. Yamashiro Y, Shimizu T, Oguchi S, et al. The estimated incidence of cystic fibrosis in Japan. J Pediatr Gastroenterol Nutr 1997;24:544-47.
24. Yoshimura K, Iizuka S, Anzai C, et al. Diffuse panbronchiolitis is closely associated with mutations of the CFTR gene. Am J Respir Critic Care Med 2000; 161: A77.
25. Yoshimura K, Wakazono Y, Iizuka S, et al. A Japanese patient homozygous for the H1085R mutation in the CFTR gene presents with a severe form of cystic fibrosis. Clin Genet 1999;56:173-5.
26. Noone PG, Knowles MR. "CFTR-opathies": disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir Res 2001;2:328-32.
27. Southern KW. Cystic fibrosis and formes frustes of CFTR-related disease. Respiration 2007;74:241-51.
28. Chillón M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of vas deferens. N Engl J Med 1995;332:1475-80.
29. Anzai C, Yoshimura K, Morokawa N, et al. High prevalence of mutations of the CFTR gene in Japanese individuals with congenital bilateral absence of the vas deferens. J Cystic Fibrosis 2003;2:14-8.
30. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-52.
31. Cohn JA, Friedman KJ, Noone PG, et al. Relation between mutations of the cystic fibrosis gene and chronic pancreatitis. N Engl J Med 1998;339:653-8.
32. Miller PW, Hamosh A, Macek M, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996;59:45-51.
33. Ehrmantraut ME, Hilligoss DM, Chernick M, et al. Pulmonary nontuberculous mycobacterial infections are highly associated with mutations in CFTR. Am J Respir Critic Care Med 2003; 167: A708.
34. Wang X, Moylan B, Leopold DA, et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 2000;284:1814-9.
35. Girodon E, Cazeneuve C, Lebargy F, et al. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet 1997;5:149-55.
36. Kudoh S, Azuma A, Yamamoto M, et al. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose of erythromycin. Am J Respir Crit Care Med 1998;157:1829-32.
37. Jaffe A, Francis J, Rosenthal M, et al. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998;351:420.
38. Wolter J, Seeney S, Bell S, et al. Effect of long term treatment with azithromycin on disease papameters in cystic fibrosis: a randomised trial. Thorax 2002;57:212-6.
39. Equi A, Balfour-Lynn IM, Bush A, et al. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 2002;360:978-84.